Skip to main content
Admetsys secures investment from T1D Exchange

T1D Exchange has made an investment of an undisclosed amount in artificial pancreas startup Admetsys as part of its initiative to support automated insulin delivery technology development. An Automated Insulin Delivery system has been developed by Admetsys to allow for more effective blood glucose control in hospitals and surgical centers.

Full Story: